<DOC>
	<DOCNO>NCT01524302</DOCNO>
	<brief_summary>This study analyze use ceftaroline CABP compare potential eradicate bacterial pathogen standard fluoroquinolone therapy . The enhanced spectrum ceftaroline compare levofloxacin may highlight investigation .</brief_summary>
	<brief_title>Pharmacodynamic Ceftaroline Levofloxacin Against Pathogens Associated With Community Acquired Bacterial Pneumonia</brief_title>
	<detailed_description />
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Pneumonia , Bacterial</mesh_term>
	<mesh_term>Levofloxacin</mesh_term>
	<mesh_term>Ofloxacin</mesh_term>
	<criteria>nonpregnant adult ( â‰¥ 18 year old ) suspect CABP admit hospital parenteral antibiotic therapy . All patient creatinine clearance ( CrCl ) &gt; 50 ml/min . pregnant nursing patient , allergy penicillin/cephalosporin antibiotic , allergy fluoroquinolones , renal hepatic failure , receive antimicrobial past 96h . Patients require antibiotic study drug also exclude .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>pneumonia</keyword>
	<keyword>ceftaroline</keyword>
	<keyword>community-aquired</keyword>
</DOC>